Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 123.60
-2.00 (-1.59%)
At close: Oct 16, 2026
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 67.73 billion as of October 16, 2026. It is the 12,222nd most valuable company in the world and the 731st biggest in India. Its market cap has increased by 157.02% in one year.
Market Cap
67.73B
Enterprise Value
68.90B
Revenue
19.51B
Global Rank
Country Rank
#731 India
PE Ratio
48.46
ChartMarket Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 67.73B, an increase of 682.25%. That is a compound annual growth rate of 7.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 67.73B | 200.95% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 149.58B |
| AstraZeneca Pharma India | 149.15B |
| Viyash Scientific | 98.66B |
| Procter & Gamble Health | 86.41B |
| Bliss GVS Pharma | 70.05B |
| Sanofi India | 67.75B |
| FDC Limited | 58.07B |
| Evonile Pharma | 46.93B |